For Early-Stage

Scale faster with
Quantiva.

We build your product, find your market, and help you raise. No decks, no hand-waving. We ship code, close deals, and operate alongside you.

Start a conversation

Why early-stage companies choose Quantiva to scale.

01

We're Entrepreneurial.

Our founders have built, funded, and sold companies. We've architected the systems, raised the capital, and closed the customers ourselves. That's why we build differently: every feature earns its place.

02

We Stretch Your Dollar.

We'll talk you out of building things you don't need yet. Off-the-shelf where it works, custom where it matters. Every dollar goes toward proving your thesis, not padding a backlog.

03

Our Industry Expertise.

Healthcare, fintech, media, commerce. We've shipped regulated products in each of these. That means fewer surprises, faster compliance, and architecture that scales with the business.

04

Our Network.

We make warm introductions to investors and buyers. Not a list of names. Actual meetings with people who write checks, sign contracts, or acquire companies like yours.

What we do

Your Launch Stack

0-1 Product Development

From concept to launch. We architect, design, and ship your MVP with production-grade infrastructure, even in regulated industries like healthcare and fintech.

Product-Market Fit

We test your assumptions with real users and real data. Rapid experimentation until we find what sticks.

Prototype to Product

You proved the concept. We make it market-ready. We take prototypes and productize them: robust architecture, production infrastructure, and the engineering rigor to scale.

Fundraising & Biz Dev

We make warm introductions and help you close. $250K to $25MM. Pitch prep, investor meetings, and sales execution.

Quantiva Acceleration Network

Ready to accelerate?

Marketing, financing, networking, engineering discounts, and advisory support for qualifying early-stage companies.

Learn more →

Don't take our word for it

The professionals at Quantiva have been an integral part of our success.

Steve Owens, COO, Quantaras

Quantiva steered us through growth & funding. Their entrepreneurial approach is key.

Michael Sprintz, MD, CEO, Cellarian

Deep experience in health technology and AI. The right choice.

David Jobes, Ph.D, President, MA BioTherapeutics

The team helped us scale our platform and introduce AI into our products.

Max Munn, CEO, Sterilumen

Ready to ship?

Let's discuss how Quantiva can accelerate your path to product-market fit.

Contact us